CONSOLIDATED STATEMENTS OF CHANGES IN SERIES B CNVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)	Total	Series B Preferred Stock [Member]	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Jul. 31, 2013	$ 374,343	$ 262,475	$ 7,050	$ 86,449	$ 11,229,864	$ (10,949,020)
Balance (Shares) at Jul. 31, 2013		262,475	7,050,000	10,806,520
Stock-based compensation	39,382				39,382	0
Common shares issued to consultants	50,000			$ 2,000	48,000	0
Common shares issued to consultants (in shares)				250,000
Common shares issued to advisory board	47,000			$ 2,000	45,000	0
Common shares issued to advisory board (in shares)				250,000
Series A convertible preferred stock issued	0		$ 2,950		(2,950)	0
Series A convertible preferred stock issued (In shares)			2,950,000
Annual 6% common stock dividend for preferred shareholders per Series B agreement	0			$ 126	3,499	(3,625)
Annual 6% common stock dividend for preferred shareholders per Series B agreement (in shares)				15,760
Common shares issued in connection with equity financing	75,000			$ 3,435	71,565	0
Common shares issued in connection with equity financing (in shares)				429,332
Common shares issued in connection with asset acquisition	5,198,375			$ 115,284	5,083,091	0
Common shares issued in connection with asset acquisition (in shares)				14,410,481
Net loss for the year	(467,751)					(467,751)
Balance at Jul. 31, 2014	5,316,349	$ 262,475	$ 10,000	$ 209,294	16,517,451	(11,420,396)
Balance (in shares) at Jul. 31, 2014		262,475	10,000,000	26,162,093
Stock-based compensation	366,395				366,395	0
Common shares issued to consultants	468,400			$ 26,408	441,992
Common shares issued to consultants (in shares)				3,300,975
Common shares issued to advisory board	280,000			$ 16,000	264,000	0
Common shares issued to advisory board (in shares)				2,000,000
Annual 6% common stock dividend for preferred shareholders per Series B agreement	0			$ 126	1,765	(1,891)
Annual 6% common stock dividend for preferred shareholders per Series B agreement (in shares)				15,760
Common shares issued in connection with equity financing	127,499			$ 11,808	115,691	0
Common shares issued in connection with equity financing (in shares)				1,475,953
Issuance of common stock to an investor as a commitment fee	95,000			$ 4,000	91,000
Issuance of common stock to an investor as a commitment fee (in shares)				500,000
Issuance of common stock in connection with convertible debt	137,000			$ 5,600	131,400
Issuance of common stock in connection with convertible debt (in shares)				700,000
Conversion of note payable to common stock	65,000			$ 14,461	50,539	0
Conversion of note payable to common stock (in shares)				1,807,579
Conversion of Series A convertible preferred stock into common stock	0		$ (10,000)	$ 160,000	(150,000)	0
Conversion of Series A convertible preferred stock into common stock (in shares)			(10,000,000)	20,000,000
Common stock issued to employees	4,780			$ 294	4,486	0
Common stock issued to employees (in shares)				36,758
Net loss for the year	(4,157,835)					(4,157,835)
Balance at Jul. 31, 2015	$ 2,702,588	$ 262,475	$ 0	$ 447,991	$ 17,834,719	$ (15,580,122)
Balance (in shares) at Jul. 31, 2015		262,475	0	55,999,118